Loraz and Cardioversion - a phase IV clinical study of FDA data

Summary:

Cardioversion is reported as a side effect among people who take Loraz (lorazepam), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Coumadin, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Cardioversion when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Cardioversion?

Cardioversion is found to be associated with 188 drugs and 345 conditions by eHealthMe. Check the latest studies of Cardioversion.

On Jul, 14, 2026

161,700 people reported to have side effects when taking Loraz.
Among them, 19 people (0.01%) have Cardioversion.

Among these 19 people:

How long have people been on Loraz when they have Cardioversion? *

What is the gender of people who have Cardioversion when taking Loraz? *

female: 73.68 %
male: 26.32 %

What is the age of people who have Cardioversion when taking Loraz? *

What are other drugs people take besides Loraz? *

What are other side effects people have besides Cardioversion? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 11 people, 57.89%
Hypotension (abnormally low blood pressure): 8 people, 42.11%
Heart Rate Increased: 7 people, 36.84%
Dyspnea (difficult or laboured breathing): 6 people, 31.58%
High Blood Pressure: 6 people, 31.58%
Ill-Defined Disorder: 6 people, 31.58%
Arrhythmias (irregular heartbeat): 6 people, 31.58%
Injury: 6 people, 31.58%
Chest Pain: 6 people, 31.58%
Cardiac Failure Congestive: 6 people, 31.58%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 26.32%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 15.79%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 10.53%
Pain: 2 people, 10.53%
Cardiac Failure Congestive: 2 people, 10.53%
Thyroid Diseases: 1 person, 5.26%
Dyspnea (difficult or laboured breathing): 1 person, 5.26%
Allergic Rhinitis: 1 person, 5.26%
Arrhythmias (irregular heartbeat): 1 person, 5.26%
Back Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and have Cardioversion?

- Check whether Cardioversion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loraz:

Loraz (165,694 reports)

Cardioversion treatments and more:

Cardioversion (2,120 reports)

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardioversion:

Cardioversion (188 drugs)

Browse all the conditions that are associated with Cardioversion:

Cardioversion (345 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.